M. Marzal-Alfaro

Error Detection and Cost Savings With an Image-Based Workflow Management System Connected to a Computerized Prescription Order Entry Program for Antineoplastic Compounding

C. Rodriguez-Gonzalez, V. Escudero-Vilaplana, I. Iglesias-Peinado, 2019, Journal of patient safety.

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

Ana Mur-Mur, María Norberta Sánchez-Fresneda, Miguel Martín, 2022, Frontiers in Oncology.

Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co‐administration

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2016, Journal of clinical pharmacy and therapeutics.

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2022, Frontiers in Public Health.

Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

C. Rodriguez-Gonzalez, C. Fernández-Llamazares, V. Escudero-Vilaplana, 2016, The Annals of pharmacotherapy.

Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2021, Frontiers in Oncology.

Linear IgA bullous dermatosis due to vancomycin and cutaneous necrosis due to terlipressin in the same patient

M. Castellanos-González, M. Marzal-Alfaro, A. Díaz-Sánchez, 2016, Indian journal of dermatology, venereology and leprology.

Impact of fampridine on quality of life: clinical benefit in real-world practice

M. Sanjurjo-Sáez, A. Herranz, J. G. García Domínguez, 2017, European journal of hospital pharmacy. Science and practice.